Manufacture

New method to control polymorphism could see “widespread use across the pharma industry”.

Formulation fit for the future of complex molecules.

Newly published research suggests that some excipients may be more "active" than previously thought.

Single-use systems have come a long way. We look at experience with the technology so far.

Can a medieval medicament find use as a modern antibacterial?

We’re making progress on standardizing single-use systems – and it could mean a more cost-effective supply chain.

Gene therapy manufacturers will need to focus on upstream filtration to minimize the risk of viral infection.

How can manufacturers avoid frustrating and inadvertent changes to the solid forms of APIs?

Lives and livelihoods depend on accelerating large molecule drug production, so biopharma companies must minimize defects and contamination.

In December, The Medicine Maker will showcase the top technologies to have been released throughout 2020. Nominations are now open.